Report CategoriesReport Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032xian22

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

date 2026-01-08

date Pharma & Healthcare

new_biaoQianAngiotensin II Type 1 Receptor (AT1R) Antagonists

According to our (Global Info Research) latest study, the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market size was valued at US$ 1548 million in 2025 and is forecast to a readjusted size of US$ 2085 million by 2032 with a CAGR of 4.4% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031xian22

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

date 2025-05-15

date Pharma & Healthcare

new_biaoQianAngiotensin II Type 1 Receptor (AT1R) Antagonists

According to our (Global Info Research) latest study, the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market size was valued at US$ 1488 million in 2024 and is forecast to a readjusted size of USD 2004 million by 2031 with a CAGR of 4.4% during review period.

USD3480.00

Add To Cart

Add To Cart

According to our (Global Info Research) latest study, the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market size was valued at US$ 1548 million in 2025 and is forecast to a readjusted size of US$ 2085 million by 2032 with a CAGR of 4.4% during review period.

USD3480.00

addToCart

Add To Cart

According to our (Global Info Research) latest study, the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market size was valued at US$ 1488 million in 2024 and is forecast to a readjusted size of USD 2004 million by 2031 with a CAGR of 4.4% during review period.

USD3480.00

addToCart

Add To Cart